Pharmacology | Virology Development of a deep learning-based quantitative structure-activity relationship model to identify potential inhibitors against the 3C-like protease of SARS-CoV-2. September 30, 2022
Bioinformatics | Pharmacology | Virology Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases. March 15, 2021
Drug Discovery | Infectious Diseases | Pharmacology Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis. November 24, 2020